Inovio Pharmaceuticals logo

Inovio Pharmaceuticals

INO | NASDAQ
Chart Builder DCF Calculator
$1.40
-$0.03 (-2.10%)
At close: Nov 16, 2026, 4:00 PM ET
$1.40
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:54 PM ET
-2.10%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
46.5
Fundamentals Average
Market Sentiment Bullish
Moat None
Sector Rank #356/1021 (Top 35%)

Key Statistics

Market Data

Market Cap $138.09M
1D Range
1.37 1.48
52W Range
0.60 2.60

Valuation (TTM)

PE -1.75
PB -4.07
EV/EBITDA -1.41

Valuation (NTM)

Forward PE N/A
Forward PEG 0.03
Price Target $4.00
Loading financial charts...

Profile

Inovio Pharmaceuticals, Inc. is a biotechnology firm dedicated to the research, development, and market introduction of DNA-based treatments. Its core mission is to prevent and cure illnesses associat...

Sector Healthcare
Industry Biotechnology
Employees 112
IPO Date Dec 8, 1998
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 10, 2026
EPS
-$0.5
Miss -141.93%
REV
$298.9K
Beat +298.53%
Next Earnings
Mar 11, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$4.00
Upside
+185.71%
Buy (3)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.